Neural stem/progenitor cells from olfactory neuroepithelium collected by nasal brushing as a cell model reflecting molecular and cellular dysfunctions in schizophrenia
暂无分享,去创建一个
A. Brunati | E. Tibaldi | L. Leanza | P. Meneguzzo | T. Toffanin | C. Idotta | Leonardo Meneghetti | Roberta Peruzzo | Angela Favaro | Roberto Saetti | M. Cadamuro | Mario Angelo Pagano | Marina Silvestrini | Giorgio Pigato | Stefano Piazza | Luigi Grassi
[1] I. Ibarra-Lecue,et al. Isolation and Differentiation of Neurons and Glial Cells from Olfactory Epithelium in Living Subjects , 2023, Molecular Neurobiology.
[2] Huajie Jin,et al. The Societal Cost of Schizophrenia: An Updated Systematic Review of Cost-of-Illness Studies , 2022, PharmacoEconomics.
[3] A. Reggiani,et al. Human-Induced Pluripotent Stem Cell Technology: Toward the Future of Personalized Psychiatry , 2022, Journal of personalized medicine.
[4] H. Kung,et al. Human iPSC-Derived Neurons as A Platform for Deciphering the Mechanisms behind Brain Aging , 2021, Biomedicines.
[5] I. Passos,et al. Accelerated aging signatures in subjects with schizophrenia and their unaffected siblings. , 2021, Journal of psychiatric research.
[6] Z. Kozmík,et al. Wnt/β-Catenin Signaling Promotes Differentiation of Ischemia-Activated Adult Neural Stem/Progenitor Cells to Neuronal Precursors , 2021, Frontiers in Neuroscience.
[7] S. Jessberger,et al. Formation and integration of new neurons in the adult hippocampus , 2021, Nature Reviews Neuroscience.
[8] J. Khokhar,et al. Cannabis Use and Mental Illness: Understanding Circuit Dysfunction Through Preclinical Models , 2021, Frontiers in Psychiatry.
[9] B. Larijani,et al. Stem cell-based models and therapies: a key approach into schizophrenia treatment , 2021, Cell and Tissue Banking.
[10] R. Roberts. Mitochondrial dysfunction in schizophrenia: with a focus on postmortem studies. , 2020, Mitochondrion.
[11] D. Schaffer,et al. β-Catenin signaling dynamics regulate cell fate in differentiating neural stem cells , 2020, Proceedings of the National Academy of Sciences.
[12] J. Meador-Woodruff,et al. Evidence for altered energy metabolism, increased lactate, and decreased pH in schizophrenia brain: A focused review and meta-analysis of human postmortem and magnetic resonance spectroscopy studies , 2020, Schizophrenia Research.
[13] L. Varela-Nallar,et al. Role of Wnt Signaling in Adult Hippocampal Neurogenesis in Health and Disease , 2020, Frontiers in Cell and Developmental Biology.
[14] M. Tremblay,et al. The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation , 2020, Frontiers in Cellular Neuroscience.
[15] J. Horáček,et al. The Role of Zebrafish and Laboratory Rodents in Schizophrenia Research , 2020, Frontiers in Psychiatry.
[16] H. Boezen,et al. A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits , 2020, Translational Psychiatry.
[17] Sarah E. Williams,et al. Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies , 2020, Molecular Psychiatry.
[18] Wanhua Shen,et al. Wnt/β-Catenin Signaling in Neural Stem Cell Homeostasis and Neurological Diseases , 2020, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[19] D. Perkins,et al. Potential Roles of Redox Dysregulation in the Development of Schizophrenia , 2020, Biological Psychiatry.
[20] A. Brand,et al. Quiescent Neural Stem Cells for Brain Repair and Regeneration: Lessons from Model Systems , 2020, Trends in Neurosciences.
[21] O. Howes,et al. Schizophrenia-An Overview. , 2020, JAMA psychiatry.
[22] S. Walitza,et al. Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings , 2020, Molecular Psychiatry.
[23] T. Werge,et al. Association of Childhood Exposure to Nitrogen Dioxide and Polygenic Risk Score for Schizophrenia With the Risk of Developing Schizophrenia , 2019, JAMA network open.
[24] M. Solmi,et al. Olfactory neuroepithelium alterations and cognitive correlates in schizophrenia , 2019, European Psychiatry.
[25] L. Scorrano,et al. Impaired Mitochondrial ATP Production Downregulates Wnt Signaling via ER Stress Induction. , 2019, Cell reports.
[26] A. Falk,et al. Stem cell models of schizophrenia, what have we learned and what is the potential? , 2019, Schizophrenia Research.
[27] R. Karry,et al. NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia , 2018, Molecular Psychiatry.
[28] E. Chen,et al. Association of an Early Intervention Service for Psychosis With Suicide Rate Among Patients With First-Episode Schizophrenia-Spectrum Disorders , 2018, JAMA psychiatry.
[29] L. Arranz,et al. Nestin-expressing progenitor cells: function, identity and therapeutic implications , 2018, Cellular and Molecular Life Sciences.
[30] Seung-Soo Baek,et al. Role of exercise on molecular mechanisms in the regulation of antidepressant effects , 2017, Journal of exercise rehabilitation.
[31] C. Pato,et al. Gene Expression in Patient-Derived Neural Progenitors Implicates WNT5A Signaling in the Etiology of Schizophrenia , 2017, Biological Psychiatry.
[32] D. Öngür,et al. Role of mitochondria and energy metabolism in schizophrenia and psychotic disorders , 2017, Schizophrenia Research.
[33] Brian D. Slaughter,et al. Dynamic regulation of Nanog and stem cell-signaling pathways by Hoxa1 during early neuro-ectodermal differentiation of ES cells , 2017, Proceedings of the National Academy of Sciences.
[34] Gerome Breen,et al. Genetic identification of brain cell types underlying schizophrenia , 2017, Nature Genetics.
[35] J. McGrath,et al. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. , 2017, The lancet. Psychiatry.
[36] Akira Sawa,et al. The Olfactory Neural Epithelium As a Tool in Neuroscience. , 2017, Trends in molecular medicine.
[37] A. Vita,et al. Schizophrenia , 2016, The Lancet.
[38] C. François,et al. The Economic Burden of Schizophrenia in the United States in 2013. , 2016, The Journal of clinical psychiatry.
[39] C. Trueta,et al. The microtubular cytoskeleton of olfactory neurons derived from patients with schizophrenia or with bipolar disorder: Implications for biomarker characterization, neuronal physiology and pharmacological screening , 2016, Molecular and Cellular Neuroscience.
[40] R. Kypta,et al. Canonical and noncanonical Wnt signaling in neural stem/progenitor cells , 2015, Cellular and Molecular Life Sciences.
[41] W. Cui,et al. Sox2, a key factor in the regulation of pluripotency and neural differentiation. , 2014, World journal of stem cells.
[42] K. Brennand,et al. Modeling Heterogeneous Patients With a Clinical Diagnosis of Schizophrenia With Induced Pluripotent Stem Cells , 2014, Biological Psychiatry.
[43] N. Šestan,et al. The developmental transcriptome of the human brain: implications for neurodevelopmental disorders. , 2014, Current opinion in neurology.
[44] T. Vos,et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.
[45] T. Dudev,et al. Wnt and lithium: a common destiny in the therapy of nervous system pathologies? , 2013, Cellular and Molecular Life Sciences.
[46] A. Mackay-Sim. Concise Review: Patient‐Derived Olfactory Stem Cells: New Models for Brain Diseases , 2012, Stem cells.
[47] A. Lahti,et al. Neurometabolites in schizophrenia and bipolar disorder — A systematic review and meta-analysis , 2012, Psychiatry Research: Neuroimaging.
[48] G. Lewis,et al. Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies , 2012, Psychological Medicine.
[49] G. Benítez-King,et al. A non-invasive method to isolate the neuronal linage from the nasal epithelium from schizophrenic and bipolar diseases , 2011, Journal of Neuroscience Methods.
[50] Tianyu Zhao,et al. Canonical Wnt signaling promotes the proliferation and neurogenesis of peripheral olfactory stem cells during postnatal development and adult regeneration , 2011, Journal of Cell Science.
[51] C. Morshead,et al. Wnt Signaling Regulates Symmetry of Division of Neural Stem Cells in the Adult Brain and in Response to Injury , 2011, Stem cells.
[52] Paul J. Harrison,et al. Genetic Neuropathology of Schizophrenia: New Approaches to an Old Question and New Uses for Postmortem Human Brains , 2011, Biological Psychiatry.
[53] Jian-ning Zhang,et al. The Wnt /β‐catenin signaling pathway in the adult neurogenesis , 2011, The European journal of neuroscience.
[54] Marcos J. Araúzo-Bravo,et al. Oct4-Induced Pluripotency in Adult Neural Stem Cells , 2009, Cell.
[55] R. Karry,et al. Neuroanatomical Pattern of Mitochondrial Complex I Pathology Varies between Schizophrenia, Bipolar Disorder and Major Depression , 2008, PloS one.
[56] Kubilay Aydin,et al. Altered Metabolic Integrity of Corpus Callosum Among Individuals at Ultra High Risk of Schizophrenia and First-Episode Patients , 2008, Biological Psychiatry.
[57] P. Boksa. Maternal infection during pregnancy and schizophrenia. , 2008, Journal of psychiatry & neuroscience : JPN.
[58] R. Karry,et al. Sp1 Expression Is Disrupted in Schizophrenia; A Possible Mechanism for the Abnormal Expression of Mitochondrial Complex I Genes, NDUFV1 and NDUFV2 , 2007, PloS one.
[59] Kazuya Iwamoto,et al. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. , 2005, Human molecular genetics.
[60] Tetsu Akiyama,et al. The Wnt/β-catenin pathway directs neuronal differentiation of cortical neural precursor cells , 2004, Development.
[61] E. Klein,et al. Mitochondrial complex i subunits expression is altered in schizophrenia: a postmortem study , 2004, Biological Psychiatry.
[62] H. Okano,et al. Expression of Tubulin Beta II in Neural Stem/Progenitor Cells and Radial Fibers During Human Fetal Brain Development , 2003, Laboratory Investigation.
[63] H. Sauer,et al. Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a 31P chemical shift spectroscopic-imaging study , 2000, Biological Psychiatry.
[64] N Schuff,et al. Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia. , 2000, The American journal of psychiatry.
[65] D. Horrobin. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia , 1998, Schizophrenia Research.
[66] Jeffrey C. Erlich,et al. Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2. , 1997, Archives of general psychiatry.
[67] L. Cavelier,et al. Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics. , 1995, Genomics.
[68] T. Asakura,et al. Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging , 1992, Acta psychiatrica Scandinavica.
[69] L. Dixon. What It Will Take to Make Coordinated Specialty Care Available to Anyone Experiencing Early Schizophrenia: Getting Over the Hump , 2017, JAMA psychiatry.
[70] I. Mosweu,et al. The Societal Cost of Schizophrenia: A Systematic Review , 2016, PharmacoEconomics.
[71] F. Gage,et al. Orphan nuclear receptor TLX activates Wnt/β-catenin signalling to stimulate neural stem cell proliferation and self-renewal , 2010, Nature Cell Biology.